Cargando…

Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma

The aim of this study is to evaluate the efficacy of insulin‐like growth factor 1 receptor (IGF‐1R) inhibitor Linsitinib, in esophageal squamous cell carcinoma (ESCC), and to characterize special biomarker to screen Linsitinib‐sensitive patients as well as explore the molecular‐resistant mechanism t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Junzhou, Chen, Kaiyan, Zhang, Fanrong, Jin, Jiaoyue, Zhang, Nan, Li, Dan, Ying, Lisha, Chen, Wei, Yu, Herbert, Mao, Weimin, Su, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463077/ https://www.ncbi.nlm.nih.gov/pubmed/28440057 http://dx.doi.org/10.1002/cam4.1068

Ejemplares similares

Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2016)

Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2017)

The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer
por: Zhang, Fanrong, et al.
Publicado: (2016)

Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma
por: Su, Dan, et al.
Publicado: (2019)

Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis
por: Ying, Lisha, et al.
Publicado: (2016)

Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway
por: Jin, Jiaoyue, et al.
Publicado: (2017)

Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
por: Huang, Minran, et al.
Publicado: (2020)

GAP43, a novel metastasis promoter in non-small cell lung cancer
por: Zhang, Fanrong, et al.
Publicado: (2018)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma
por: Wang, Lu, et al.
Publicado: (2018)

Adult height, body mass index change, and body shape change in relation to esophageal squamous cell carcinoma risk: A population‐based case‐control study in China
por: Yang, Xiaorong, et al.
Publicado: (2019)

Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer
por: Guo, Yu, et al.
Publicado: (2022)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
por: Chen, Shuchen, et al.
Publicado: (2020)

Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma
por: Arora, Mohit, et al.
Publicado: (2023)

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden
por: Ekheden, Isabella, et al.
Publicado: (2022)

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015)

High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
por: Su, Dan, et al.
Publicado: (2017)

ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4
por: Sun, Gaozhong, et al.
Publicado: (2020)

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
por: Gulbins, Anne, et al.
Publicado: (2023)

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness
por: Xu, Fang‐Ping, et al.
Publicado: (2016)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

MT3‐MMP down‐regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma
por: Xue, Zengfu, et al.
Publicado: (2016)

Prognostic impact of MutT homolog‐1 expression on esophageal squamous cell carcinoma
por: Akiyama, Shingo, et al.
Publicado: (2016)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
por: Chai, Yuhang, et al.
Publicado: (2019)

The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer
por: Pan, Zhiwen, et al.
Publicado: (2016)

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor: Findings from the ESCCAPE multicountry case‐control studies
por: Narh, Clement T., et al.
Publicado: (2021)

AFAP1‐AS1 is upregulated and promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis
por: Luo, Hong‐lei, et al.
Publicado: (2016)

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design
por: Zheng, Yuyan, et al.
Publicado: (2021)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

Exosomal Sonic Hedgehog derived from cancer‐associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma
por: Zhao, Guiping, et al.
Publicado: (2020)

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
por: Chiappori, Alberto A., et al.
Publicado: (2016)

IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer
por: Kruger, Dinja T., et al.
Publicado: (2019)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bl0seph15tv36obl45h5k7ffpd